课题基金 / 基金详情

ACTIVE IMMUNOTHERAPY FOR PATIENTS WITH ANAPLASTIC GLIOMA

ACTIVE IMMUNOTHERAPY FOR PATIENTS WITH ANAPLASTIC GLIOMA
间变性神经胶质瘤患者的主动免疫治疗
批准号：
6244907
负责人：
STEVEN K GUDEMAN
金额：
$1.34万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-01-06 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6244907
关键词：
carmustine clinical research clinical trials combination cancer therapy glioma human subject human therapy evaluation immunomodulators levamisole neoplasm /cancer chemotherapy neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy tissue /cell culture

项目摘要

项目成果

STEVEN K GUDEMAN的其他基金

相似基金

相关文献

中文摘要
翻译
这是一项关于主动免疫抗肿瘤效果的研究。 组织培养脑胶质瘤细胞制剂与佐剂混合。病人 随机接受冷冻或未冷冻U-251免疫 胶质瘤细胞和左旋咪唑、放射治疗和BCNU治疗，或 常规放疗加BCNU治疗。
英文摘要
This is a study of the antitumor effect of active immunization with a tissue culture glioma cell preparation mixed with adjuvant. Patients were randomized to receive immunization with frozen or unfrozen U-251 glioma cells and treated with levamisole, radiotherapy, and BCNU, or treated conventionally with radiotherapy and BCNU.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BCNU, PROCARBAZINE AND RADIOTHERAPY IN TREATMENT OF ANAPLASTIC GLIOMAS
IMMUNOTHERAPY FOR MALIGNANT GLIOMAS
ACTIVE IMMUNOTHERAPY FOR PATIENTS WITH ANAPLASTIC GLIOMA
TREATMENT OF ANAPLASTIC GLIOMAS WITH CONCOMITANT CISPLATIN AND RADIOTHERAPY
海外基金